EMSTRONG Platform Expands to Treat Sexual Dysfunction, Tapping into ‘Intimate Wellness’ Market

NEW YORK, NY – November 19, 2025

The Rise of ‘Intimate Wellness’ Technology

The medical technology landscape is witnessing a surge in devices focused on previously underserved areas of health – particularly those relating to intimate wellness and sexual function. Rejuva Fresh is capitalizing on this trend with expanded CE certification for its EMSTRONG platform, now extending its application beyond urinary incontinence to include treatment for sexual dysfunction linked to weak pelvic floor muscles. This move positions the company at the forefront of a burgeoning market driven by increased awareness, reduced stigma, and advancements in non-invasive technologies.

For years, pelvic floor health has been a hushed topic, often addressed only in the context of post-partum recovery or urinary incontinence. However, a growing number of individuals are recognizing the importance of a strong pelvic floor for overall health, sexual function, and quality of life. This shift in perception, coupled with advancements in medical technology, is fueling demand for innovative solutions that address these concerns. According to industry analysts, the pelvic floor dysfunction treatment market is projected to surpass $4.5 billion by 2032, with a compound annual growth rate of 6.5%. The sexual wellness device market is similarly robust, estimated at over $12.61 billion in 2024 and expected to reach $21.67 billion by 2032.

“There’s a clear trend towards proactive health management, and people are becoming more comfortable addressing issues that were once considered taboo,” said one healthcare professional specializing in women’s health. “Patients are actively seeking solutions for sexual dysfunction and pelvic floor weakness, and they’re demanding non-invasive options that fit their lifestyles.”

Beyond Kegels: Evaluating EMSTRONG’s Efficacy

The EMSTRONG platform utilizes High-Intensity Concentrated Magnetic Muscle Training (HICMMT) technology to stimulate deep pelvic floor muscles. Unlike traditional treatments like Kegel exercises, which rely on conscious muscle contractions, EMSTRONG induces thousands of supramaximal contractions in a single 30-minute session. This allows for a more intense and effective workout, potentially leading to faster and more significant improvements in pelvic floor strength and function.

Rejuva Fresh claims that EMSTRONG is “7-8 times more effective than traditional pelvic floor exercises.” This claim is based on clinical outcomes demonstrating improvements in sexual satisfaction, orgasm quality, vaginal tissue tightness, and pelvic muscle endurance. While the specific data quantifying this superiority remains primarily held by the company, initial research suggests that HICMMT technology shows promise for treating pelvic floor dysfunction. Studies have shown that high-intensity electromagnetic stimulation can significantly improve anatomical and functional outcomes in patients with pelvic floor weakness.

However, healthcare professionals emphasize the need for rigorous clinical validation. “While the technology sounds promising, it's crucial to have independent, peer-reviewed studies that specifically compare EMSTRONG to traditional treatments,” said one urologist specializing in male sexual health. “We need to see concrete evidence that supports the claims of superior efficacy.”

Rejuva Fresh emphasizes the training provided to practitioners using the EMSTRONG system, highlighting the importance of proper technique and individualized treatment plans. The company’s approach signals a broader trend towards empowering healthcare providers with the knowledge and skills necessary to deliver effective and personalized care.

Navigating a Competitive Landscape & Business Strategy

Rejuva Fresh operates in a competitive market, facing established players offering similar technologies and treatments. The company differentiates itself through a combination of innovative technology, competitive pricing, and a direct-to-business sales model. By bypassing traditional distribution channels, Rejuva Fresh can offer its equipment at a lower cost while maintaining a focus on quality and customer support.

According to company representatives, the EMShape® Neo device is one of the fastest-selling body contouring devices, with over 5000 clinics in the US utilizing their equipment. Rejuva Fresh highlights its multiple shape patents and 19 registered trademarks in Asia as evidence of its commitment to innovation and intellectual property protection.

While the company remains unfunded, relying on internal resources for growth, it is actively expanding its reach through partnerships with healthcare providers and distributors. Rejuva Fresh's emphasis on building strong relationships with its customers and providing comprehensive training and support is a key factor in its success. This approach allows the company to establish a loyal customer base and differentiate itself in a crowded market. The company’s direct-to-business model, coupled with a lean operational structure, allows it to compete effectively with larger, more established players in the aesthetic device industry.

The company is positioning itself as a disruptive force in the market, offering high-quality equipment at competitive prices and challenging the status quo of traditional distribution channels.